Asymptomatic liver enzyme elevations may occur in individual cases. Therefore liver enzyme monitoring should be considered during the first 6 to 12 months of treatment. In evaluable cases these changes were reversible on discontinuation of Acarbose (Glucobay) therapy.
Safety and efficacy of Acarbose (Glucobay) in patients under 18 years of age have not been established.